These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 6696534)
1. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension. Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534 [TBL] [Abstract][Full Text] [Related]
2. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow. Rector WG; Hossack KF J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616 [TBL] [Abstract][Full Text] [Related]
3. Nitroprusside prevents adverse hemodynamic effects of vasopressin. Gelman S; Ernst EA Arch Surg; 1978 Dec; 113(12):1465-71. PubMed ID: 736781 [TBL] [Abstract][Full Text] [Related]
4. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Bosch J; Kravetz D; Rodes J Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897 [TBL] [Abstract][Full Text] [Related]
5. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension. Mols P; Hallemans R; Melot C; Lejeune P; Naeije R J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445 [TBL] [Abstract][Full Text] [Related]
6. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone. Iwao T; Toyonaga A; Ikegami M; Oho K; Sumino M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095 [TBL] [Abstract][Full Text] [Related]
7. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension. Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307 [TBL] [Abstract][Full Text] [Related]
8. The effects of the combination of phentolamine and vasopressin on hepatic and systemic hemodynamics in cirrhotic portal hypertensive dog model. Dan ZL; Zhao Q; Li SB J Tongji Med Univ; 1991; 11(1):35-8. PubMed ID: 1875450 [TBL] [Abstract][Full Text] [Related]
9. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection. Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649 [TBL] [Abstract][Full Text] [Related]
10. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420 [TBL] [Abstract][Full Text] [Related]
11. Effect of vasopressin and somatostatin on hemodynamics and blood gases in patients with liver cirrhosis. Naeije R; Hallemans R; Mols P; Mélot C; Reding P Crit Care Med; 1982 Sep; 10(9):578-82. PubMed ID: 6125342 [TBL] [Abstract][Full Text] [Related]
12. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin. Hallemans R; Naeije R; Mols P; Mélot C; Reding P Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502 [TBL] [Abstract][Full Text] [Related]
13. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension. Westaby D; Gimson A; Hayes PC; Williams R Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465 [TBL] [Abstract][Full Text] [Related]
14. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044 [TBL] [Abstract][Full Text] [Related]
15. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis. García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729 [TBL] [Abstract][Full Text] [Related]
16. Nitroglycerin for portal hypertension. A controlled comparison of the hemodynamic effects of graded doses. Rector WG; Hossack KF; Ready JB J Hepatol; 1990 May; 10(3):375-80. PubMed ID: 2114438 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis. Lee FY; Tsai YT; Lin HC; Lee SD; Hsia HC; Lin WJ; Wang SS; Lai KH; Lo KJ J Hepatol; 1992 May; 15(1-2):54-8. PubMed ID: 1506656 [TBL] [Abstract][Full Text] [Related]
18. Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine. Moreau R; Cailmail S; Lebrec D Liver; 1994 Feb; 14(1):45-9. PubMed ID: 8177029 [TBL] [Abstract][Full Text] [Related]
19. The effect of vasopressin and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension. Rabol A; Juhl E; Schmidt A; Winkler K Digestion; 1976; 14(3):285-9. PubMed ID: 955334 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis. Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]